Very low dose quetiapine-induced galactorrhea in combination with venlafaxine [2]

Human Psychopharmacology

Volumn 19, Issue 6, 2004, Pages 433-434

  Pae, Chi Un ^a   Kim, Jung Jin ^a   Lee, Chang Uk ^a   Chae, Jeong Ho ^a   Lee, Soo Jung ^a   Lee, Chul ^a   Paik, In Ho ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN; QUETIAPINE; VENLAFAXINE;

ADULT; CASE REPORT; DEPRESSION; DRUG DOSE REGIMEN; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEMALE; GALACTORRHEA; HUMAN; LETTER; LOW DRUG DOSE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SOMATIC DELUSION; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; CYCLOHEXANOLS; DEPRESSION; DIBENZOTHIAZEPINES; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; GALACTORRHEA; HUMANS; PROLACTIN;

EID: 4444291868     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.606     Document Type: Letter

References (7)

1. Arvanitis LA, Miller BG. Multiple fixed doses of 'Seroquel' (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. 1997. The Seroquel Trial 13 Study Group. Biol Psychiatry 42: 233-246.
2. Astrazeneca Pharmaceuticals LP. Seroquel (quetiapine fumarate). SCI 64231-00 (Rev 04/03, 1-29).
3. Dickson RA, Seeman MV, Corenblum B. 2000. Hormonal side effects in women: typical versus atypical antipsychotic treatment. J Clin Psychiatry 61(Suppl 3): 10-15.
4. Keller R, Mongini F. 2002. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia. Neurol Sci 23: 233-235.
5. Kim KS, Pae CU, Chae JH, et al. 2002. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. J Clin Psychiatry 63: 408-413.
6. Kingsbury SJ, Castelo C, Abulseoud O. 2002. Quetiapine for olanzapine-induced galactorrhea. Am J Psychiatry 159: 1061.
7. Sternbach H. 2003. Venlafaxine-induced galactorrhea. J Clin Psychopharmacol 23: 109-110.